title: [Echocardiographic evaluation of anti-tumor necrosis factor-alpha therapy with infliximab in patients without cardiac pathologies].
abstract: In the course of heart failure, plasmatic levels of Tumor Necrosis Factor-alpha (TNF-alpha) are high and are related to prognosis and mortality. Infliximab, a recombinant chimeric antibody anti-TNF-alpha, was used in heart failure with disappointing results, similar to those obtained with other biological drugs.The aim of this study was the echocardiographic evaluation of infliximab infusion in nine patients without cardiac pathologies. The findings demonstrate a reduction of sistolic function and a modification of diastolic function after infliximab infusion in patients without cardiopathy. This study confirms the protective role played by TNFalpha on the myocardium, as suggested by previous experimental studies.
authors.affiliation: UO Medicina Interna, Ospedale SS Salvatore di S. Giovanni in Persiceto, Azienda USL di Bologna. gianbra@iol.it
authors.forename: Gianpaolo
authors.initials: G
authors.lastname: Bragagni
authors.forename: Federico
authors.initials: F
authors.lastname: Lari
authors.forename: Gaetano
authors.initials: G
authors.lastname: Magenta
authors.forename: Raffaele
authors.initials: R
authors.lastname: Brogna
authors.forename: Giorgio
authors.initials: G
authors.lastname: Zoli
mesh_terms: D000328:Adult; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000188:drug therapy*; D003424:Crohn Disease / Q000188:drug therapy*; D003971:Diastole / Q000502:physiology; D004195:Disease Models, Animal; D004452:Echocardiography; D015150:Echocardiography, Doppler; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006333:Heart Failure / Q000097:blood / Q000000981:diagnostic imaging / Q000401:mortality / Q000503:physiopathology; D006801:Humans; D000069285:Infliximab; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D008875:Middle Aged; D013599:Systole / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab